Inhibikase Therapeutics(IKT) - Prospectus

Table of Contents As filed with the Securities and Exchange Commission on June 18, 2024. Registration No. 333-[●] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT (State or other jurisdiction of incorporation or organization) Delaware 2836 26-3407249 (Primary Standard Industrial Classification Code Number) 3350 Riverwood Parkway SE, Suite 1900 Atlanta, GA 30339 (I.R.S. Employer Identification Number) (678) 392-3419 (Address, including zip code, and tele ...